Dr. Raj is involved in basic, translational and clinical research in prostate and bladder cancers. His laboratory research examines signal transduction pathways mediating cell survival in prostate cancer, utilizing nanotechnology based therapeutic approaches. He is involved in several clinical trials examining novel imaging techniques, neoadjuvant and adjuvant chemotherapies and minimally invasive therapies for urologic cancers. His clinical interests include optimizing outcomes for treatment of various urologic malignancies.
RESEARCH INTERESTS
Urologic cancers
Nanotechnology
Imaging
Outcomes
Tumor markers
RECENT PUBLICATIONS
Huang WC, Raj GV, Serio A, Vickers A, Russo P, "The Effect of Nephrectomy on Renal Function in Patients with Renal Cortical Tumors" Lancet Oncology, 7(9):735-40, 2006
Raj GV, Bach A, Iasonos A, Korets R, Blitstein J, Hann L, Russo P, "Utility of Pre-Operative Color Doppler Ultrasonography in Predicting the Histology of Renal Lesions" J Urology, 177:53-58, 2007
Raj GV, Tal R, Vickers A, Bochner BH, Serio A, Donat SM, Herr H, Olgac S, Dalbagni G, "Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer" Cancer, 107(9):2167-72, November 2006
Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P, "Incidence of benign lesions for clinically localized renal masses < 7 cm in radiologic diameter: Influence of sex" J Urology, 176:2391-2396, 2006
Raj, GV, Bochner B, "Radical cystectomy and lymphadenectomy for invasive bladder cancer: Towards the evolution of an optimal surgical standard" Seminars in Oncology, In press 2006
SIGNIFICANT PUBLICATIONS
Raj GV, Iasonos A, Herr HW, Donat SM, Formulas estimating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer, "Formulas estimating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer" J Clinic Oncology, 24(19):3095-100, 2006
Raj GV, Bochner BH, Serio AM, Vickers A, Donat SM, Herr H, Lin O, Dalbagni G, "Natural history of positive urinary cytology after radical cystectomy" J Urology, 176(5):2000-5, November 2006
Raj GV, Bochner BH, Vickers A, Teper E, Lin O, Donat SM, Herr H, Dalbagni G, "Assocation between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract" J Urology, 175(6):2038-2041, discussion 2041, June 2006
Raj GV, Sekula J, Kim J, Madden JF, Daaka Y, "Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-KB" Prostate, 61:105-113, 2004
Raj GV, Partin AW, Polascik TJ, "Utility of 111 In-Capromab pendetide immunoscintigraphy in the detection of early recurrent disease after radical prostatectomy" Cancer, 94:987-96, 2002
Point and right click (click and hold for Mac users) your mouse onand select "Save this link (or target) as..." option to save the file to your local computer.